Patrys Limited logo

Patrys Limited

ASX:PAB.AX

Overview | Financials
Company Name Patrys Limited
Symbol PAB.AX
Currency AUD
Price 0.007
Market Cap 14,402,150
Dividend Yield 0%
52-week-range 0.005 - 0.011
Industry Biotechnology
Sector Healthcare
CEO Dr. James A. Campbell B.Sc., MBA, Ph.D.
Website https://www.patrys.com

An error occurred while fetching data.

About Patrys Limited

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain

Related Stocks

Pharmaxis Ltd logo

Pharmaxis Ltd

PXS.AX

0.028 AUD

Dimerix Limited logo

Dimerix Limited

DXB.AX

0.38 AUD

Imagion Biosystems Limited logo

Imagion Biosystems Limited

IBX.AX

0.023 AUD

PainChek Limited logo

PainChek Limited

PCK.AX

0.032 AUD

Vectus Biosystems Limited logo

Vectus Biosystems Limited

VBS.AX

0.08 AUD

Cynata Therapeutics Limited logo

Cynata Therapeutics Limited

CYP.AX

0.19 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD